Drug
Fedratinib
Fedratinib: highest development phase Phase 1/2, developed by Bristol-Myers Squibb. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Bristol-Myers Squibb
Trials
| Drug | Phase | Indication |
|---|---|---|
| Fedratinib NCT04446650 | Phase 1/2 | Primary Myelofibrosis |
Latest
No recent events.
Follow Fedratinib on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.